Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
36.04
-0.36 (-0.99%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
14,694,618
Open
36.31
Bid (Size)
36.03 (100)
Ask (Size)
36.06 (3,500)
Prev. Close
36.40
Today's Range
35.89 - 36.49
52wk Range
35.85 - 81.44
Shares Outstanding
N/A
Dividend Yield
3.24%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
1 Reason Eli Lilly Stock Is Still a Buy
↗
Today 6:20 EDT
Eli Lilly is much more than just a weight loss stock.
Via
The Motley Fool
Topics
Artificial Intelligence
Novo Nordisk: A Strong Contender in the Pharmaceutical Arena
↗
March 27, 2026
Could Novo Nordisk be the hidden gem you've been searching for? Join us as we evaluate its current market position and future prospects in this insightful episode.
Via
The Motley Fool
Performance
YTD
-31.2%
-31.2%
1 Month
-5.6%
-5.6%
3 Month
-31.2%
-31.2%
6 Month
-35.2%
-35.2%
1 Year
-48.6%
-48.6%
More News
Read More
Eli Lilly Shares Slip Despite Positive Eczema Trial Results: Why the Market Reacted Coolly
March 27, 2026
Via
MarketMinute
Eli Lilly vs Novo Nordisk: Which Obesity Drug Stock Is the Better Buy?
↗
March 27, 2026
Via
The Motley Fool
Could Buying Eli Lilly Today Set You Up for Life?
↗
March 26, 2026
Via
The Motley Fool
Topics
Intellectual Property
What's Happening With Novo Nordisk Stock Today?
↗
March 26, 2026
Via
Benzinga
Wave Life Sciences Shakes Biotech Sector with Breakthrough Obesity Data: A New Era for ‘Quality’ Weight Loss
March 26, 2026
Via
MarketMinute
Kodiak Sciences Surges 19% as Phase 3 GLOW2 Trial Delivers Vital Win for Diabetic Retinopathy Treatment
March 26, 2026
Via
MarketMinute
Surging Oil Prices Spark Market Jitters
↗
March 25, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Stocks
The $6.7 Billion Pivot: A Deep Dive into Terns Pharmaceuticals (TERN) and the Merck Acquisition
March 25, 2026
Via
Finterra
Topics
Initial Public Offering
Intellectual Property
World Trade
Think Novo Nordisk Can't Keep Up in the GLP-1 Market? Its Latest Drug Approval Could Be a Game Changer
↗
March 24, 2026
Via
The Motley Fool
Institutional Titans Bet Big on Amgen as Dividend Yield Hits 2.9% Benchmark
March 23, 2026
Via
MarketMinute
Topics
ETFs
Earnings
Got $1,500? Is It Better to Buy Bitcoin, or Viking Therapeutics?
↗
March 22, 2026
Via
The Motley Fool
Topics
Intellectual Property
Should You Buy Eli Lilly Stock Before April 10?
↗
March 22, 2026
Via
The Motley Fool
Is This Stock a Buy on the Dip?
↗
March 21, 2026
Via
The Motley Fool
This Hims & Hers Move Could Destroy Competitors
↗
March 21, 2026
Via
The Motley Fool
Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up?
↗
March 20, 2026
Via
The Motley Fool
Is It Too Late to Buy Eli Lilly?
↗
March 19, 2026
Via
The Motley Fool
Topics
Intellectual Property
1 Reason I'm Never Selling Novo Nordisk Stock
↗
March 19, 2026
Via
The Motley Fool
Hims & Hers (HIMS) 2026 Deep Dive: The $1.15B Eucalyptus Deal and the Branded Pivot
March 18, 2026
Via
Finterra
Topics
Intellectual Property
Hims & Hers Opens Up Pre-Launch Waitlist For Ozempic And Wegovy Following Partnership With Novo Nordisk
↗
March 18, 2026
Via
Stocktwits
The Best Healthcare Stocks to Buy With $50 Right Now
↗
March 18, 2026
Via
The Motley Fool
Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics
↗
March 17, 2026
Via
The Motley Fool
Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move
↗
March 17, 2026
Via
The Motley Fool
Topics
Stocks
LLY Shares Dive On Analyst Downgrade Citing Obesity Market Overestimation Concerns, But Retail Dismisses ‘Absurd’ Selloff
↗
March 17, 2026
Via
Stocktwits
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 36.04
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 03/27/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.